Oligodendrocyte injury in multiple sclerosis: A role for p53

Journal of Neurochemistry

Volumn 85, Issue 3, 2003, Pages 635-644

  Wosik, Karolina ^a   Antel, Jack ^a   Kuhlmann, Tanja ^b   Brück, Wolfgang ^b   Massie, Bernard ^c   Nalbantoglu, Josephine ^a  

^a MCGILL UNIVERSITY   (Canada)

^b HUMBOLDT UNIVERSITY   (Germany)

^c NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Adenovirus; Death receptor; Fas; TNF related apoptosis inducing ligand

Indexed keywords

ADENOVIRUS VECTOR; CASPASE; FAS LIGAND; PROTEIN P53; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL LOSS; CELL PROTECTION; CONTROLLED STUDY; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; INFLAMMATION; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NEUROPROTECTION; OLIGODENDROGLIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADENOVIRIDAE;

EID: 0037997993     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01674.x     Document Type: Article

References (60)

1. Akassoglou K., Bauer J., Kassiotis G., Pasparakis M., Lassmann H., Kollias G. and Probert L. (1998) Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am. J. Pathol. 153, 801-813.
2. Atwal J. K., Massie B., Miller F. D. and Kaplan D. R. (2000) The TrkB-Shc site signals neuronal survival and local axon growth via MEK and P13-kinase. Neuron 27, 265-277.
3. Banasiak K. J. and Haddad G. G. (1998) Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res. 797, 295-304.
4. Beltinger C., Fulda S., Kammertoens T., Meyer E., Uckert W. and Debatin K. M. (1999) Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc. Natl Acad. Sci. USA 96, 8699-8704.
5. Bonetti B., Pohl J., Gao Y. L. and Raine C. S. (1997) Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J. Immunol. 159, 5733-5741.
6. Bruck W., Porada P., Poser S., Rieckmann P., Hanefeld F., Kretzschmar H. A. and Lassmann H. (1995) Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 38, 788-796.
7. Brysk M. M., Selvanayagam P., Arany I., Brysk H., Tyring S. K. and Rajaraman S. (1995) Induction of apoptotic nuclei by interferon-gamma and by predesquamin in cultured keratinocytes. J. Interferon Cytokine Res. 15, 1029-1035.
8. Chen P., Tian J., Kovesdi I. and Bruder J. T. (1998) Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis. J. Biol. Chem. 273, 5815-5820.
9. Chiou S. K., Tseng C. C., Rao L. and White E. (1994) Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68, 6553-6566.
10. Chopp M., Li Y., Zhang Z. G. and Freytag S. O. (1992) p53 expression in brain after middle cerebral artery occlusion in the rat. Biochem. Biophys. Res. Commun. 182, 1201-1207.
11. Crumrine R. C., Thomas A. L. and Morgan P. F. (1994) Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J. Cereb Blood Flow Metab. 14, 887-891.
12. D'Souza S., Alinauskas K., McCrea E., Goodyer C. and Antel J. P. (1995) Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J. Neurosci. 15, 7293-7300.
13. D'Souza S. D., Bonetti B., Balasingam V., Cashman N. R., Barker P. A., Troutt A. B., Raine C. S. and Antel J. P. (1996) Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp Med. 184, 2361-2370.
14. Dowling P., Shang G., Raval S., Menonna J., Cook S. and Husar W. (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184, 1513-1518.
15. Evan G. and Littlewood T. (1998) A matter of life and cell death. Science 281, 1317-1322.
16. Everett H. and McFadden G. (1999) Apoptosis: an innate immune response to virus infection. Trends Microbiol. 7, 160-165.
17. Genain C. P., Cannella B., Hauser S. L. and Raine C. S. (1999) Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5, 170-175.
18. Genini D., Sheeter D., Rought S., Zaunders J. J., Susin S. A., Kroemer G., Richman D. D., Carson D. A., Corbeil J. and Leoni L. M. (2001) HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J. 15, 5-6.
19. Guan B., Yue P., Clayman G. L. and Sun S. Y. (2001) Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene. J. Cell Physiol. 188, 98-105.
20. Hansen R. and Oren M. (1997) p53; from inductive signal to cellular effect. Curr. Opin. Genet. Dev. 7, 46-51.
21. Hashimoto S., Ishii A. and Yonehara S. (1991) The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody. Int. Immunol. 3, 343-351.
22. Huang W.-X., Huang M. P., Gomes M. A. and Hillert J. (2000) Apoptosis mediators fasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS. Neurology 55, 928-934.
23. Jurewicz A., Biddison W. E. and Antel J. P. (1998) MHC class I-restricted lysis of human oligodendrocytes by myelin basic protein peptide-specific CD8 T lymphocytes. J. Immunol. 160, 3056-3059.
24. Katayose D., Gudas J., Nguyen H., Srivastava S., Cowan K. H. and Seth P. (1995) Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Clin. Cancer Res. 1, 889-897.
25. Kaya S. S., Mahmood A., Li Y., Yavuz E., Goksel M. and Chopp M. (1999) Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain. Brain Res. 818, 23-33.
26. Krishna M., Woda B., Savas L., Baker S. and Banner B. (1995) Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease. Mod. Pathol. 8, 654-657.
27. Ladiwala U., Li H., Antel J. P. and Nalbantoglu J. (1999) p53 induction by tumor necrosis factor-alpha and involvement of p53 in cell death of human oligodendrocytes. J. Neurochem. 73, 605-611.
28. Lassman H. (1998) McAlpine's Multiple Sclerosis (Compston A., Ebers G., Lassmann H., McDonald I., Matthews B., and Wekerle H., eds), pp. 323-358. Churchill Livingstone, London.
29. Li Y., Chopp M., Zhang Z. G., Zaloga C., Niewenhuis L. and Gautam S. (1994) p53-immunoreactive protein and p53 mRNA expression after transient middle cerebral artery occlusion in rats. Stroke 25, 849-855.
30. Li H., Lochmuller H., Yong V. W., Karpati G. and Nalbantoglu J. (1997) Adenovirus-mediated wild-type p53 gene transfer and overexpression induces apoptosis of human glioma cells independent of endogenous p53 status. J. Neuropathol. Exp. Neurol. 56, 872-878.
31. Lochmuller H., Jani A., Huard J., Prescott S., Simoneau M., Massie B., Karpati G. and Acsadi G. (1994) Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (delta E1 + delta E3) during multiple passages in 293 cells. Hum. Gene Ther. 5, 1485-1491.
32. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M. and Lassmann H. (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122, 2279-2295.
33. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M. and Lassmann H. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47, 707-717.
34. Massie B., Dionne J., Lamarche N., Fleurent J. and Langelier Y. (1995) Improved adenovirus vector provides herpes simplex virus ribonucleotide reductase R1 and R2 subunits very efficiently. Biotechnology (NY) 13, 602-608.
35. Massie B., Couture F., Lamoureux L., Mosser D. D., Guilbault C., Jolicoeur P., Belanger F. and Langelier Y. (1998) Inducible overexpression of a toxic protein by an adenovirus vector with a tetracycline-regulatable expression cassette. J. Virol. 72, 2289-2296.
36. Medema J. P., Scaffidi C., Kischkel F. C., Shevchenko A., Mann M., Krammer P. H. and Peter M. E. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16, 2794-2804.
37. Micheau O., Solary E., Hammann A. and Dimanche-Boitrel M. T. (1999) Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem. 274, 7987-7992.
38. Morrison R. S. and Kinoshita Y. (2000) The role of p53 in neuronal cell death. Cell Death Differ. 7, 868-879.
39. Muller M., Wilder S., Bannasch D., Israeli D., Lehlbach K., Li-Weber M., Friedman S. L., Galle P. R., Stremmel W., Oren M. and Krammer P. H. (1998) p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med. 188, 2033-2045.
40. Mundle S. D. and Raza A. (2002) Defining the dynamics of self-assembled Fas-receptor activation. Trends Immunol. 23, 187-194.
41. Nitsch R., Bechmann I., Deisz R. A., Haas D., Lehmann T. N., Wendling U. and Zipp F. (2000) Human brain-cell death induced by tumournecrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet 356, 827-828.
42. Noseworthy J. H. (1999) Progress in determining the causes and treatment of multiple sclerosis. Nature 399, A40-A47.
43. Owen-Schaub L. B., Zhang W., Cusack J. C., Angelo L. S., Santee S. M., Fujiwara T., Roth J. A., Deisseroth A. B., Zhang W. W., Kruzel E. and Radinsky R. (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell Biol. 15, 3032-3040.
44. Pouly S., Becher B., Blain M. and Antel J. P. (2000) Interferon-gamma modulates human oligodendrocyte susceptibility to Fas- mediated apoptosis. J. Neuropathol Exp Neurol. 59, 280-286.
45. Raine C. S., Bonetti B. and Cannella B. (1998) Multiple sclerosis: expression of molecules of the tumor necrosis factor ligand and receptor families in relationship to the demyelinated plaque. Rev. Neurol. (Paris) 154, 577-585.
46. Raine C. S., Cannella B., Hauser S. L. and Genain C. P. (1999) Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46, 144-160.
47. Rensing-Ehl A., Frei K., Flury R., Matiba B., Mariani S. M., Weller M., Aebischer P., Krammer P. H. and Fontana A. (1995) Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 25, 2253-2258.
48. Rokhlin O. W., Gudkov A. V., Kwek S., Glover R. A., Gewies A. S. and Cohen M. B. (2000) p53 is involved in tumor necrosis factor-alpha-induced apoptosis in the human prostatic carcinoma cell line LNCaP. Oncogene 19, 1959-1968.
49. Sheikh M. S., Burns T. F., Huang Y., Wu G. S., Amundson S., Brooks K. S., Fornace A. J. Jr and el Deiry W. S. (1998) p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res. 58, 1593-1598.
50. Shisler J., Yang C., Walter B., Ware C. F. and Gooding L. R. (1997) The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis. J. Virol. 71, 8299-8306.
51. Sommer I. and Schachner M. (1981) Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev. Biol. 83, 311-327.
52. Stefferl A., Brehm U. and Linington C. (2000) The myelin oligodendrocyte glycoprotein (MOG): a model for antibody-mediated demyelination in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neural Transm. Suppl. 58, 123-133.
53. Stempien-Otero A., Karsan A., Comejo C. J., Xiang H., Eunson T., Morrison R. S., Kay M., Winn R. and Harlan J. (1999) Mechanisms of hypoxia-induced endothelial cell death. Role of p53 in apoptosis. J. Biol. Chem. 274, 8039-8045.
54. Takimoto R. and el Deiry W. S. (2000) Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site. Oncogene 19, 1735-1743.
55. Thornborrow E. C. and Manfredi J. J. (2001) The tumor suppressor protein p53 requires a cofactor to activate transcriptionally the human BAX promoter. J. Biol. Chem. 276, 15598-15608.
56. Tollefson A. E., Hermiston T. W., Lichtenstein D. L., Colle C. F., Tripp R. A., Dimitrov T., Toth K., Wells C. E., Doherty P. C. and Wold W. S. (1998) Forced degradation of Fas inhibits apoptosis in adenovirus-infected cells. Nature 392, 726-730.
57. Tollefson A. E., Toth K., Doronin K., Kuppuswamy M., Doronina O. A., Lichtenstein D. L., Hermiston T. W., Smith C. A. and Wold W. S. (2001) Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. J. Virol. 75, 8875-8887.
58. Watanabe H., Ohta S., Kumon Y., Sakaki S. and Sakanaka M. (1999) Increase in p53 protein expression following cortical infarction in the spontaneously hypertensive rat. Brain Res. 837, 38-45.
59. Xiang H., Hochman D. W., Saya H., Fujiwara T., Schwartzkroin P. A. and Morrison R. S. (1996) Evidence for p53-mediated modulation of neuronal viability. J. Neurosci. 16, 6753-6765.
60. Yeung M. C. and Lau A. S. (1998) Tumor suppressor p53 as a component of the tumor necrosis factor-induced, protein kinase PKR-mediated apoptotic pathway in human promonocytic U937 cells. J. Biol. Chem. 273, 25198-25202.